BUZZ-Indian pharma stocks gain after US resumes funding HIV treatments

Shares of Indian Pharma companies which make drugs for HIV rise between 2% to 13%

U.S. decides to resume funding HIV treatment after pausing the foreign aid on Jan. 26

Strides Pharma SRID.NS up 13%, Laurus Labs LAUL.NS rise 8%, Aurobindo Pharma ARBN.NS rise 3% and Cipla CIPL.NS up 2%

Strides, which reported 77% rise in Q3 profit earlier in the day, is top gainer on the pharma index .NIPHARM which is up 1%

Since Jan. 26, LAUL down 10% and SRID fell 5% as of last close, while SRID was largely flat and Cipla was up 1%